We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Say Guidance on Patient Experience Data Should Cover All Development Stages
Drugmakers Say Guidance on Patient Experience Data Should Cover All Development Stages
Commenting on FDA’s planned patient-focused drug development guidance, industry stakeholders said the agency needs to clarify how it will incorporate patient experience data into specific stages of development.